NCT06932575

Brief Summary

The goal of this clinical trial is to evaluate the effect of andullation therapy in the management of pain and anxiety that occur in the patient follow-up after oocyte retrieval. The main questions it aims to answer are:

  • Does andullation therapy after oocyte retrieval reduce pain measured immediately after the end of therapy?
  • Does andullation therapy after oocyte retrieval reduce anxiety measured immediately after the end of therapy? Researchers will compare experimental and control groups to see if andullation therapy reduce pain and anxiety after oocyte retrieval. Participants will:
  • Take State Anxiety Inventory before oocyte retrieval.
  • Take andullation therapy or not after oocyte retrieval
  • Take the State Anxiety Inventory and Visual Analog Scale at 1 hour, 1.5 hours, 6 hours, and 24 hours after oocyte retrieval.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 10, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
Last Updated

April 20, 2025

Status Verified

April 1, 2025

Enrollment Period

8 months

First QC Date

April 10, 2025

Last Update Submit

April 16, 2025

Conditions

Keywords

InfertilityOocyte RetrievalAndullationPainAnxiety

Outcome Measures

Primary Outcomes (1)

  • Pain Severity after Oocyte Retrieval

    Measure the relationship between pain severity in experimental and control groups after oocyte retrieval using Visual Analog Scale. In a 10-point VAS scoring: 0 indicates no pain, 1-3 indicates mild pain, 4-6 indicates moderate pain, and 7-10 indicates severe pain

    1, 1.5, 6, and 24 hours after oocyte retrieval

Secondary Outcomes (1)

  • Anxiety Level after Oocyte Retrieval

    1, 1.5, 6, and 24 hours after oocyte retrieval

Study Arms (2)

The experimental group received andullation therapy

EXPERIMENTAL

The experimental group received andullation therapy for 30 minutes using an andullation therapy bed after oocyte retrieval

Device: Andullation Therapy Bed

The control group only applied scales

NO INTERVENTION

The control group did not receive andullation therapy after oocyte retrieval.

Interventions

andullation therapy applied for 30 minutes after oocyte retrieval

The experimental group received andullation therapy

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having an oocyte retrieval procedure regardless of the cause of infertility,
  • Being at least literate,
  • Being between the ages of 18-49,
  • Accepting to participate in the study,
  • Pain level above 0, as measured by the VAS scale, applied after the oocyte retrieval procedure.

You may not qualify if:

  • Having chronic pain problems,
  • Having communication problems,
  • Having any nervous or musculoskeletal disorders that would prevent them from lying flat on the massage bed,
  • Having any diagnosed psychiatric illness,
  • Refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskisehir Osmangazi University

Eskişehir, Eskişehir, 26040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaInfertilityPainAnxiety Disorders

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsGenital DiseasesUrogenital DiseasesMental Disorders

Study Officials

  • Assoc. Prof. VEHBİ YAVUZ TOKGÖZ

    Eskisehir Osmangazi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 10, 2025

First Posted

April 17, 2025

Study Start

April 11, 2023

Primary Completion

December 12, 2023

Study Completion

December 12, 2023

Last Updated

April 20, 2025

Record last verified: 2025-04

Locations